Anebulo Pharmaceuticals, Inc.
Institutional Ownership & Holdings Analysis
About
anebulo-pharmaceuticals is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | 22NW, LP(2025-03-31) | $20.1M |
2 | Nantahala Capital Management, LLC(2025-03-31) | $3.9M |
3 | MANGROVE PARTNERS IM, LLC(2025-03-31) | $3.3M |
4 | MORGAN STANLEY(2025-03-31) | $519.0K |
5 | LVW Advisors, LLC(2025-03-31) | $454.5K |
6 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $267.1K |
7 | VANGUARD GROUP INC(2025-03-31) | $265.9K |
8 | MILLENNIUM MANAGEMENT LLC(2025-03-31) | $206.7K |
9 | Ikarian Capital, LLC(2025-03-31) | $205.0K |
10 | KING LUTHER CAPITAL MANAGEMENT CORP(2024-12-31) | $100.2K |
11 | GOLDMAN SACHS GROUP INC(2025-03-31) | $62.3K |
12 | HRT FINANCIAL LP(2025-03-31) | $30.0K |
13 | BOOTHBAY FUND MANAGEMENT, LLC(2025-03-31) | $24.5K |
14 | CITADEL ADVISORS LLC(2025-03-31) | $14.5K |
15 | BlackRock, Inc.(2025-03-31) | $7.5K |
16 | Tower Research Capital LLC (TRC)(2025-03-31) | $4.6K |
17 | BANK OF AMERICA CORP /DE/(2025-03-31) | $4.5K |
18 | JPMORGAN CHASE & CO(2025-03-31) | $10 |
19 | UBS Group AG(2025-03-31) | $1 |
20 | CONCOURSE FINANCIAL GROUP SECURITIES, INC.(2025-03-31) | $0 |
#122NW, LP
As of 2025-03-31
Value:$20.1M
As of 2025-03-31
Value:$3.9M
As of 2025-03-31
Value:$3.3M
As of 2025-03-31
Value:$519.0K
As of 2025-03-31
Value:$454.5K
As of 2025-03-31
Value:$267.1K
As of 2025-03-31
Value:$265.9K
As of 2025-03-31
Value:$206.7K
As of 2025-03-31
Value:$205.0K
As of 2024-12-31
Value:$100.2K
As of 2025-03-31
Value:$62.3K
As of 2025-03-31
Value:$30.0K
As of 2025-03-31
Value:$24.5K
As of 2025-03-31
Value:$14.5K
As of 2025-03-31
Value:$7.5K
As of 2025-03-31
Value:$4.6K
As of 2025-03-31
Value:$4.5K
As of 2025-03-31
Value:$10
#19UBS Group AG
As of 2025-03-31
Value:$1
As of 2025-03-31
Value:$0
Total Institutional Holders:20
Top 10 Holders Own:99.5%